Switch theme
Sign up to access all valuation multiples
Core Scientific Inc is engaged in designing, building and operating digital infrastructure for high-performance computing. The business operates in three operating segments; Digital Asset Self-Mining, consisting of performing digital asset mining for the own account, Digital Asset Hosted Mining, consisting of providing hosting services to third parties for digital asset mining, and HPC Hosting, consisting of providing hosting services to third parties for graphics processing unit (GPU) based HPC hosting operations. The majority of revenue is derived from the Digital Asset Self-Mining Segment.
2020
325
LTM Revenue $477M
LTM EBITDA $127M
$3.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Core Scientific has a last 12-month revenue (LTM) of $477M and a last 12-month EBITDA of $127M.
In the most recent fiscal year, Core Scientific achieved revenue of $511M and an EBITDA of -$1.2B.
Core Scientific expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Core Scientific valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $477M | XXX | $511M | XXX | XXX | XXX |
| Gross Profit | $122M | XXX | $121M | XXX | XXX | XXX |
| Gross Margin | 26% | XXX | 24% | XXX | XXX | XXX |
| EBITDA | $127M | XXX | -$1.2B | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | -227% | XXX | XXX | XXX |
| EBIT | -$47.3M | XXX | -$12.2M | XXX | XXX | XXX |
| EBIT Margin | -10% | XXX | -2% | XXX | XXX | XXX |
| Net Profit | -$552M | XXX | -$1.3B | XXX | XXX | XXX |
| Net Margin | -116% | XXX | -258% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $254M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Core Scientific's stock price is $11.
Core Scientific has current market cap of $3.2B, and EV of $3.7B.
See Core Scientific trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.7B | $3.2B | XXX | XXX | XXX | XXX | $-2.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Core Scientific has market cap of $3.2B and EV of $3.7B.
Core Scientific's trades at 7.2x EV/Revenue multiple, and -3.2x EV/EBITDA.
Equity research analysts estimate Core Scientific's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Core Scientific has a P/E ratio of -5.7x.
See valuation multiples for Core Scientific and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3.2B | XXX | $3.2B | XXX | XXX | XXX |
| EV (current) | $3.7B | XXX | $3.7B | XXX | XXX | XXX |
| EV/Revenue | 7.7x | XXX | 7.2x | XXX | XXX | XXX |
| EV/EBITDA | 28.8x | XXX | -3.2x | XXX | XXX | XXX |
| EV/EBIT | -77.6x | XXX | -299.9x | XXX | XXX | XXX |
| EV/Gross Profit | 30.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | -5.7x | XXX | -2.4x | XXX | XXX | XXX |
| EV/FCF | -23.8x | XXX | -70.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCore Scientific's last 12 month revenue growth is 29%
Core Scientific's revenue per employee in the last FY averaged $1.6M, while opex per employee averaged $0.4M for the same period.
Core Scientific's rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Core Scientific's rule of X is 100% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Core Scientific and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 29% | XXX | 32% | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | -227% | XXX | XXX | XXX |
| EBITDA Growth | 60% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 17% | XXX | -197% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 100% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $1.6M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 26% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Presight AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Pointerra | XXX | XXX | XXX | XXX | XXX | XXX |
| Beamtree | XXX | XXX | XXX | XXX | XXX | XXX |
| Unith | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Core Scientific acquired XXX companies to date.
Last acquisition by Core Scientific was XXXXXXXX, XXXXX XXXXX XXXXXX . Core Scientific acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Core Scientific founded? | Core Scientific was founded in 2020. |
| Where is Core Scientific headquartered? | Core Scientific is headquartered in United States of America. |
| How many employees does Core Scientific have? | As of today, Core Scientific has 325 employees. |
| Who is the CEO of Core Scientific? | Core Scientific's CEO is Mr. Adam Taylor Sullivan. |
| Is Core Scientific publicy listed? | Yes, Core Scientific is a public company listed on NAS. |
| What is the stock symbol of Core Scientific? | Core Scientific trades under CORZ ticker. |
| When did Core Scientific go public? | Core Scientific went public in 2024. |
| Who are competitors of Core Scientific? | Similar companies to Core Scientific include e.g. Presight AI, Benevolent AI, Pointerra, Beamtree. |
| What is the current market cap of Core Scientific? | Core Scientific's current market cap is $3.2B |
| What is the current revenue of Core Scientific? | Core Scientific's last 12 months revenue is $477M. |
| What is the current revenue growth of Core Scientific? | Core Scientific revenue growth (NTM/LTM) is 29%. |
| What is the current EV/Revenue multiple of Core Scientific? | Current revenue multiple of Core Scientific is 7.7x. |
| Is Core Scientific profitable? | Yes, Core Scientific is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Core Scientific? | Core Scientific's last 12 months EBITDA is $127M. |
| What is Core Scientific's EBITDA margin? | Core Scientific's last 12 months EBITDA margin is 27%. |
| What is the current EV/EBITDA multiple of Core Scientific? | Current EBITDA multiple of Core Scientific is 28.8x. |
| What is the current FCF of Core Scientific? | Core Scientific's last 12 months FCF is -$154M. |
| What is Core Scientific's FCF margin? | Core Scientific's last 12 months FCF margin is -32%. |
| What is the current EV/FCF multiple of Core Scientific? | Current FCF multiple of Core Scientific is -23.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
